Evaluation of the Effectiveness, Safety and Tolerability of LevoCept (Levonorgestrel-Releasing Intrauterine System) for Long-Acting Reversible Contraception
Phase of Trial: Phase II
Latest Information Update: 19 Feb 2017
At a glance
- Drugs Levonorgestrel (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- Sponsors ContraMed
- 02 Dec 2016 According to a ContraMed media release, a total of six subjects were enrolled at the first two centers of the study till date.
- 22 Nov 2016 Status changed from not yet recruiting to recruiting.
- 14 Sep 2016 New trial record